Revolution Medicines (RVMD.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec12

Analyst Maintains Buy Rating on Revolution Medicines

02:17

Dec4

Rhumbline Advisers cut holdings in Revolution Medicines in Q2

10:55

Dec3

TD Cowen Analyst Maintains Buy Rating on Revolution Medicines

10:52

Nov29

Revolution Medicines insider Mark Goldsmith sells stocks

09:22

Nov26

Revolution Medicines Director Sells Common Stock

21:16

Nov20

Revolution Medicines insiders sold $939,008 worth of stock

21:43

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -305.21 M, EPS -1.6128

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -247.79 M, EPS -1.3139

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -213.42 M, EPS -1.1343

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More